A Study of a FimH Blocker, EB8018, in Crohn's Disease Patients

Condition:   Crohn Disease Intervention:   Drug: EB8018 (First-in-class FimH blocker) Sponsor:   Enterome Active, not recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials